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OBJECTIVES The aim of this study was to evaluate the therapeutic effects of folic acid in the pig model of
hyperhomocysteinemia.
BACKGROUND We have previously shown that pigs fed a methionine-rich diet develop hyperhomocysteine-
mia, arterial lesions and thrombotic events. Elevated homocysteine level is an independent
risk factor for atherosclerosis that can be markedly lowered with daily folic acid administra-
tion. However, it is not known whether this treatment can prevent arterial lesions.
METHODS Three groups of pigs were studied: 8 control subjects received a standard diet; 8 received a
methionine-rich diet for four months; 8 received a methionine-rich diet for 1 month and then
the methionine-rich diet 1 5 mg/day folic acid for 3 months. At month 4 after hemodynamic
investigation, all the pigs were sacrificed.
RESULTS Control animals developed few usual vascular streaks. All the pigs fed a methionine-rich diet
without folic acid treatment developed hyperhomocysteinemia (10.3 6 1.3 mmol/liter at basal
state, 18.2 6 2.5 mmol/liter at one month and 14.6 6 3.8 mmol/liter at four months),
hemodynamic abnormalities and diffuse arterial lesions with smooth muscle cell hyperplasia,
endothelial alterations and elastic lamina dislocation. In this group, one pig died of venous
thromboembolism and one of myocardial infarction. The pigs fed a methionine-rich diet 1
folic acid displayed similar arterial lesions and two had thrombotic events (one myocardial
infarction and one pulmonary embolism), despite normalization of homocysteine levels
(10.9 6 1.3 mmol/liter at basal state, 19.5 6 2.5 mmol/liter at one month and 11.4 6 3.8
mmol/liter at four months).
CONCLUSIONS In the pig model of hyperhomocysteinemia, 5 mg/day folic acid did not prevent arterial
lesions or thrombotic events. (J Am Coll Cardiol 1999;34:274–9) © 1999 by the American
College of Cardiology
Mild hyperhomocysteinemia is a recognized independent
risk factor for coronary artery disease, peripheral vascular
disease, cerebrovascular disease and venous thromboembo-
lism (1–3). Several causes of elevated plasma homocysteine
levels have been identified. The strongest predictor of
plasma total homocysteine level is the serum folate level
(4–8). This vitamin is involved in the remethylation of
homocysteine into methionine. Low folate levels are fre-
quent among elderly people, are mainly related to low
dietary intake, and are associated with a plasma homocys-
teine level elevation of about 40% (9,10). For folate levels
below the lower limit, Kang et al. (10) reported that 84% of
patients have hyperhomocysteinemia. Recent works have
shown that in folate-deficient patients, mild hyperhomocys-
teinemia may result from an interaction with the genetic
polymorphism of the methylene tetrahydrofolate reductase,
an enzyme involved in the remethylation of homocysteine
(11,12).
The treatments known to decrease plasma homocysteine
levels are based upon oral or intramuscular administration of
folates, vitamin B-6 and vitamin B-12. In subjects with mild
hyperhomocysteinemia, folic acid 0.65 to 15 mg/day can
lower homocysteinemia of about 20% to 45%, even in the
presence of normal serum vitamins levels or in subjects with
genetically caused hyperhomocysteinemia (10,13–15). More-
over, this treatment can improve arterial endothelial function in
hyperhomocysteinemic subjects (16). These findings could
have nutritional policy implications such as flour and other
cereal product fortification with folic acid (8). However, it is
unknown whether or not folic acid can prevent atheroscle-
rosis or vascular events in mild hyperhomocysteinemia (2).
In the present work we evaluated the therapeutic effects of
folic acid treatment on the thrombotic and vascular conse-
quences of hyperhomocysteinemia in the pig model.
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METHODS
Animals, diets and treatments. The animals were handled
in accordance with the INSERM U-278 Animal Care and
Use Committee, as previously described (17,18). At basal
state (M0), twenty-four 4.5-month-old Pietrin pigs (body
weight 5 44 kg) received either the methionine-rich diet
previously reported to induce hyperhomocysteinemia (hy-
perhomocysteinemic pigs, [M group and M 1 F groups],
n 5 16 pigs) or a standard diet (controls, [C group], n 5 8
pigs). The size of each group was chosen to allow a
comparison of vascular histology and hemodynamics and
was compatible with pig breeding and housing.
Hyperhomocysteinemic pigs were fed the methionine-
rich diet for four months. Methionine-rich diet consisted of
purified, delipidated caseinates (30 g/100), potato starch (59
g/100), large bran cellulose (7 g/100), fish starch (2 g/100),
vitamins, salts and hog nectar (2 g/100). The 500-g daily
ration corresponded to 1850 kcal and contained 3.45 g
methionine, 2 mg vitamin B-6, 20 mg vitamin B-12, and
220 mg folic acid. One month after the beginning of this
diet, eight of these pigs were given folic acid 5 mg daily for
the last three months (M1F group) and eight were not (M
group). Folic acid (5 mg tablet) (Speciafoldine, Rhoˆne-
Poulenc Rorer, France) was inserted in the food.
The eight pigs of the control group (C) received for four
months a standard diet consisting of soybean proteins (30
g/100), potato starch (59 g/100), bran cellulose (7 g/100),
fish starch (2 g/100), vitamins, mineral salt and hog nectar
(2 g/100) (breeding diet 127, UAR, Villemoison sur Orge,
France). The 500-g daily dose corresponded to 1850 kcal
and contained 1.28 g methionine, 2 mg vitamin B-6, 20 mg
vitamin B-12, and 220 mg folic acid.
At four months (M4), following hemodynamic investi-
gations, pigs were sacrificed for pathologic analysis.
Blood collection and serum biochemistry. Blood samples
were drawn in the morning (i.e., 24 h after the last
treatment and feeding). Serum standard biochemistry was
determined at M0 and M4. Serum methionine and homo-
cysteine levels were determined at M0, M1, and M4
following the previously described method (17). The sam-
ples of plasma were stored at 220°C, then analyzed after
reduction with dithiothreitol and deproteinization with
sulfosalicylic acid. Reduced plasma samples then were chro-
matographed on a cationic ion exchange resin Beckman AA
6 300 amino acid analyzer (Beckman Instruments, Gagny,
France) with lithium citrate buffer as eluent solvent and
ninhydrin as revealing agent.
Histologic analysis of the vasculature. Histologic changes
were evaluated in the abdominal aorta (in a 1.5-cm-long
segment of abdominal aorta located at mid-distance be-
tween the left renal artery and aortic trifurcation), in the left
interventricular coronary artery (in a 0.5-cm-long segment
immediately after the circumflex artery bifurcation from the
left coronary trunk), in the renal arteries (in a 1-cm-long
segment at 1.5 cm from the ostium), and in the common
carotid bifurcation (in a 0.5-cm-long segment of the distal
left common carotid artery centered on the internal and
external carotid artery bifurcations). Immediately after sac-
rifice, the segments of pig arteries were carefully rinsed in
ice-cold isotonic saline solution and fixed in formol for 18 h.
Serial slides were obtained and alternately stained with
hematoxylin-eosin-safranine for general observation, Mas-
son trichrome for connective and nuclear compounds, and
orcein for elastic tissue. Computerized morphodensitomet-
ric analysis of orcein-stained pathologic slides of abdominal
aorta and left interventricular coronary artery was performed
to evaluate the elastin content within the media and to give
a quantitative characterization of elastic structure.
Arterial structures were investigated using a light video
microscope (Axioplan, Zeiss, Jena, Germany) linked to a
SAMBA 2005 automatic image analyzer (TITN-Alcatel,
Grenoble, France). A 103 eyepiece and a 103 objective for
the abdominal aorta, or a 203 objective for the left
interventricular coronary artery allowed observation of the
whole width of the media within a single image. After
selection of a zone of interest, the image was digitized on a
640 3 480 pixel frame using a normalized 256-gray-level
scale. The analysis was carried out on a manually defined
standardized rectangular field, whose major axis was a radial
segment and whose width was fixed at 200 mm for the
abdominal aorta and 100 mm for the left interventricular
coronary artery. Stained elastic elements were selected onto
the image by interactively setting a gray-level threshold. The
morphometric parameters (length and area) of each selected
object were then automatically computed. Objects with an
area of less than 10 mm2 were excluded as unidentifiable.
Assuming homogeneity at staining, the mean thickness of
each object was calculated as proportional to its mean
residual gray level after subtracting the background, and its
volume was calculated from its area and mean thickness.
Medial elastin concentration was evaluated as the volume
density of the stained component within the media by
dividing the summed volumes of detected objects by the
volume of the analyzed portion of slide, as previously
described (19).
Abbreviations and Acronyms
M0 5 basal state
M1 5 month 1
M4 5 month 4
C group 5 control group
M group 5 pigs receiving a methionine-rich diet
M1F group 5 pigs receiving a methionine-rich
diet1folates
D 5 external arterial diameter
P 5 blood pressure
Q 5 blood flow
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Scanning electron microscopy was performed as previ-
ously described (20). Briefly, a segment of artery was
removed and sectioned longitudinally in two halves. Each
specimen was fixed with ice-cold 2.5% buffered glutaralde-
hyde for 1 h and then dehydrated in progressive acetone and
dried by the critical-point method with acetone and liquid
carbon dioxide. After coating with 30 nm gold coating layer,
scanning electron microscopy was performed with a JEOL
JSM 35 CF microscope.
Hemodynamics. Hemodynamics of iliac and renal arteries
were determined invasively at M4 following a previously
described method (17). Briefly, external arterial diameter
(D) was determined with a periarterial probe consisting of
two piezoelectric crystals. Blood pressure (P) was deter-
mined using a 5 PR 249 3F pressure-sensor mikrotip
catheter (Millar, Houston, Texas). Blood flow (Q) was
measured using a T 206 periarterial ultrasonic blood flow
probe (Transonic System). Individual-average diameter,
flow, and pressure were obtained after digitization from 20
cycles, whose synchronization was triggered by the R-wave
of the electrocardiogram (ECG). From these data, we
determined the average population of pulsatile flow-
pressure plots, arterial compliance (DV/DP), impedance
(DP/DQ), stiffness (DP/DD), Young’s elastic modulus and
midwall arterial stress.
Statistical analysis. Data are reported as mean 6 SD.
Statistical analysis was performed using GB-stat (Dynamic
Microsystems). Morphometry was analyzed with one-way
analysis of variance (ANOVA), the hemodynamics and
biochemical analysis with ANOVA for repeated measures,
and followed by a pairwise comparison in case of statistical
significance using the Scheffe´ test. A value of p , 0.05 was
considered statistically significant.
RESULTS
Vascular events. All animals remained healthy throughout
the treatment period and survived until euthanasia in the C
(control) group. In the M group (methionine-rich diet), one
pig died from pathologically confirmed pulmonary embo-
lism at 3.5 months and one died of myocardial infarction at
four months at the time of surgery for hemodynamic study.
In the M1F group, one animal died from pulmonary
embolism with extensive thrombosis in inferior vena cava
and right atrium at 3.5 months; one pig died from myocar-
dial infarction at the time of surgery.
Biochemistry. At basal state and at M4, the three groups
did not differ significantly for standard biochemistry (Table
1). Folic acid treatment did not modify plasma fibrinogen,
International Normalized Ratio and hematologic parame-
ters (white and red blood cell counts, mean globular volume,
platelet count; data not shown).
At basal state, serum methionine and homocysteine levels
were similar in the three groups. Homocysteine (M0:
10.9 6 2.1 mmol/liter; M4: 10.8 6 1.6 mmol/liter) did not
change in the C group. In the M group, plasma homocys-
teine concentration was higher at M1 than at M0 (18.2 6
2.5 vs. 10.3 6 1.3 mmol/liter, p , 0.05) and remained high
at M4 (14.6 6 3.8, p 5 0.08 vs. M0). In the M1F group,
plasma homocysteine concentration was higher at M1 than
at M0 (19.5 6 2.5 vs. 10.9 6 1.3 mmol/liter, p , 0.05) and
returned to the basal level at M4 on folic acid treatment
(11.4 6 3.8 mmol/liter). Methionine levels did not change
between M0 and M4 in the C and M groups, and
significantly increased in the M1F group (M0: 24.3 6 6.2,
M4: 31.7 6 7.2 mmol/liter, p , 0.05).
Histopathology of vessels. In control animals, left inter-
ventricular coronary arteries and to a lesser extent, abdom-













Protein (G/liter) 67.8 6 15.6 64.7 6 7.6 61.2 6 6.9 65.8 6 5.5 67.3 6 3.7 67.7 6 7.2
Urea (mmol/liter) 3.8 6 0.1 4.4 6 1.6 3.8 6 0.9 4.0 6 0.5 10.6 6 2.6 10.3 6 2.6
Creatinine (mmol/liter) 156.7 6 8.7 156.3 6 33.9 161.2 6 17.7 155.4 6 6.6 141.6 6 24.3 131.3 6 16.6
Glucose (mmol/liter) 6.6 6 1.6 4.8 6 1.8 4.8 6 2.4 6.1 6 1.6 4.3 6 0.4 3.4 6 0.8
Calcium (mmol/liter) 2.5 6 0.1 2.6 6 0.1 2.5 6 0.1 2.4 6 0.1 2.4 6 0.1 2.4 6 0.1
Triglycerides (mmol/liter) 0.4 6 0.2 0.6 6 0.4 0.3 6 0.2 0.3 6 0.1 0.2 6 0.1 0.2 6 0.1
HDL cholesterol (mmol/liter) 0.4 6 0.4 0.8 6 0.3 0.2 6 0.1 0.4 6 0.1 0.6 6 0.1 0.7 6 0.1
LDL cholesterol (mmol/liter) 1.0 6 0.2 1.0 6 0.5 0.7 6 1.5 1.0 6 0.5 0.9 6 0.1 0.9 6 0.1
Cholesterol (mmol/liter) 1.8 6 0.7 1.8 6 0.8 1.6 6 0.1 1.8 6 0.2 1.7 6 0.2 1.8 6 0.2
ASAT (IU/liter) 28.8 6 0.1 26.6 6 6.2 25.6 6 9.1 29.4 6 6.7 51.3 6 20.1 49.7 6 23.3
ALAT (IU/liter) 49.1 6 1.6 31.1 6 10.9 51.8 6 12.4 57.2 6 25.1 60.2 6 19.3 65.1 6 14.1
Gamma GT (IU/liter) 44.2 6 12.6 60.8 6 29.2 64.1 6 11.6 55.3 6 13.7 67.2 6 19.7 78.1 6 15.1
Cysteine (mmol/liter) 95.4 6 13.1 113.0 6 17.1 103.1 6 10.1 101.0 6 5.3 73.2 6 7.8 78.0 6 14.0
Methionine (mmol/liter) 22.7 6 1.3 30.1 6 8.0 24.2 6 6.2 23.4 6 3.1 21.68 6 4.6 31.7 6 7.2
Homocysteine (mmol/liter) 10.9 6 2.1 10.3 6 1.3 10.8 6 2.4 10.8 6 1.6 14.6 6 3.8 11.4 6 2.9
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inal aortas exhibited few vascular streaks. In the M and
M1F groups, the abdominal aorta, carotid bifurcations, left
interventricular coronary artery and renal arteries showed
alterations of endothelial cells, elastic lamina disruption and
smooth muscular cell hyperplasia, characteristics of the
homocysteine-induced lesions in the vascular walls of hy-
perhomocysteinemic animals. The disorganization of elastic
fibers was diffuse and present in all studied arteries. Aortic
and carotid lesions were barely protruding in the vascular
lumen. In the coronary and renal arteries, medial and
intimal hyperplasia caused the lesion to bulge in the lumen.
In the M and M1F groups, scanning electronic microscopy
of the vascular luminal surface showed endothelial cells
heterogeneous in shape, bulging in the vascular lumen, with
sparse intercellular “holes” (Fig. 1).
The endothelial surface was smooth without intercellular
holes in the C group. Medial thickness was similar in the
three groups at histomorphometry (Table 2). Medial elastin
concentration was lower in hyperhomocysteinemic animals
than in the controls. Medial elastin concentration was
similar in the M and M1F groups (Table 2).
Hemodynamics. Hemodynamic study was achieved in six
pigs of each group (Table 3).
RENAL VERSUS ILIACS HEMODYNAMICS. There were no sig-
nificant differences in blood pressure or mean flow between
iliacs and renal arteries in the C group. Wall thickness-mean
radius ratio and arterial stiffness were higher in renal than in
iliac arteries. Arterial compliance and pulsatility were lower in
renal arteries, indicating that the elastic component is promi-
nent in the iliacs, in contrast with the renal arteries in which
the viscous part is the major wall component.
EFFECT OF HYPERHOMOCYSTEINEMIA. Blood pressure was
not modified in the M group versus the C group. In iliac
arteries, a nonsignificant decrease in compliance and an in-
Figure 1. Photomicrographs of renal (A,a) and iliac (B,b) arteries of pigs fed the control (small letters) or the methionine-rich diet
(capitals). The transverse sections (black letters) were obtained at 3150 after orcein staining. They show elastic lamina fragmentation
(black arrow) and cellular hyperplasia (black arrowheads) in the media. The views of the luminal surface of the endothelium (white
letters) were obtained with scanning electron microscopy at 3750. Endothelial cell bulging in the arterial lumen is associated with
intercellular holes (white arrows).
Table 2. Histomorphometric Analysis of the Abdominal Aorta and of the Left Interventricular Coronary Artery in the Three Groups
Abdominal Aorta Coronary Artery
C Group M Group M1F Group C Group M Group M1F Group
Medial elastin concentration
(volume %) 6 SD
11.7 6 0.9 9.6 6 2.8* 9.0 6 1.0* 9.9 6 1.3 6.3 6 1.4* 7.4 6 1.4*
Medial thickness
(mm) 6 SD
527 6 33 536 6 57 548 6 43 298 6 57 341 6 71 308 6 45
*p , 0.05 versus controls.
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crease in mean flow were observed. In renal arteries, an increase
occurred in arterial diameter without significant modification
of mean blood flow in the hyperhomocysteinemic animals.
EFFECT OF FOLIC ACID TREATMENT. Iliac arteries of the
M1F group showed the same increase in mean flow as in
the M group. In the renal bed, there was the same increase
in arterial diameter as in the M group; peripheral resistances
were higher in M1F group than in the M and C groups.
Flow-pressure relationship was not modified by folic acid.
DISCUSSION
The main result of our study is that a treatment with folic
acid failed to prevent arterial lesions and thrombotic events
in the hyperhomocysteinemic pigs.
Hyperhomocysteinemic pig model. This pig model has
been selected rather than another animal model because of two
main reasons. First, results of sulfur amino acid metabolism
experiments in this species more closely match the results
obtained in humans than do those from rabbits and rats (17).
Second, we have previously shown that minipigs fed a
methionine-rich diet for four months develop hyperhomocys-
teinemia, thrombotic events and arterial lesions similar to those
of homocystinuria (17). In the present study, a four-month
methionine-rich diet consistently elicited arterial lesions in all
studied vascular beds. The observed lesions in pigs fed a
methionine-rich diet were similar to those previously de-
scribed, as associated hypertrophy of endothelial cells, hyper-
plasia of smooth muscle cells and major elastic lamina dislo-
cations. Videodensitometric analysis confirmed the decrease in
arterial elastin content of hyperhomocysteinemic animals (19).
For these analyses, we used a conventional fixation in formol,
which can create tissue shrinkage.
However, there was a clear difference at conventional
histology and at videodensitometry between controls and
hyperhomocysteinemic animals. Using scanning electron
microscopy, we have more acutely described endothelial
alterations. The endothelial cells were bulging in vascular
lumen and in some places were separated by intercellular
holes ;2 mm in diameter. However, these lesions may be
overestimated because of fixation artifacts. These observa-
tions are in agreement with other previous experimental
models, either in vivo or in vitro, which usually found
morphologic and functional alterations of endothelial cells
submitted to high homocysteine concentrations.
Hemodynamic alterations were less apparent in the renal
and iliac beds than the alterations previously described in
the abdominal aorta (17). Thrombotic events occurred in 4
of the 16 pigs fed a methionine-rich diet; two had myocar-
dial infarction and two had venous thromboembolism. We
did not find abnormalities of plasma fibrinogen nor of
International Normalized Ratio in the pigs fed a
methionine-rich diet. As marked endothelial alterations
were found in these pigs, we believe that thrombotic events
Table 3. Hemodynamics and Wall Mechanics in the Iliac and Renal Arteries of Pigs
C Group M Group M1F Group
p-
ANOVAIliacs Renals Iliacs Renals Iliacs Renals
Pmax (mm Hg) 142 6 17 128 6 22 122 6 28 125 6 18 128 6 23 143 6 20 0.8
Pmin (mm Hg) 111 6 10 89.5 6 35 94.1 6 23 82.8 6 23 87.6 6 23 106 6 16 0.6
DP (mm Hg) 30.0 6 9.2 28.7 6 3.5 27.3 6 11.5 42.3 6 6.4 40.3 6 13 36.3 6 8.1 0.26
Pmean (mm Hg) 123 6 12 111 6 15 107 6 25 100 6 21 104 6 22 124 6 18 0.99
Qmax (ml/min) 575 6 126 267 6 108 897 6 292 415 6 144 1049 6 299† 254 6 59 , 0.0001
Qmin (ml/min) 90 6 87 177 6 38 267 6 143* 210 6 77 142 6 111 156 6 30 0.8
DQ (ml/min) 483 6 92 96.2 6 31 629 6 189 171 6 94 906 6 424* 97.6 6 34 , 0.0001
Qmean (ml/min) 234 6 129 218 6 54 527 6 292 306 6 102 445 6 273 197 6 49 0.01
Dmax (cm) 3 103 584 6 49 347 6 7 620 6 72 540 6 24† 583 6 45 550 6 39† , 0.0001
Dmin (cm) 3 103 581 6 49 335 6 15 616 6 69 539 6 24† 581 6 43 547 6 38† , 0.0001
DD (cm) 3 105 350 6 66 180 6 89 400 6 306 110 6 12 265 6 207 273 6 202 0.02
D mean (cm) 3 103 581 6 49 344 6 9 618 6 71 540 6 24† 582 6 44 544 6 33† , 0.0001
Hm (%) 3 104 166 6 1 385 6 222 167 6 1 284 6 3 166 6 1 284 6 2 0.0002
Co (ml/mm Hg) 3 103 1166 6 699 295 6 112 634 6 343 304 6 191 458 6 225 499 6 172 0.002
PR (%) 3 103 622 6 311 596 6 162 452 6 320 183 6 44* 337 6 75 390 6 287 0.3
Zc (mm Hg/ml) 3 103 89 6 18 383 6 58 67 6 15 190 6 77† 55 6 14 418 6 168‡ , 0.0001
PR (mm Hg/ml) 3 103 734 6 174 578 6 151 281 6 134† 511 6 55 381 6 215† 980 6 326†‡ , 0.0001
ArS (mm Hg/mm) 1618 6 628 2471 6 995 2228 6 976 3151 6 401 1910 6 552 2700 6 1312 0.004
Ep (mm Hg/mm) 3 1022 467 6 106 199 6 66 684 6 251 656 6 66† 487 6 99 472 6 222 0.05
Sm (kN/m2) 289 6 63 85 6 37 320 6 74 155 6 6 272 6 53 141 6 35 , 0.0001
*p , 0.05 versus controls. †p , 0.01 versus controls. ‡p , 0.01: M1F significantly different from M group.
Results are mean 6 SD for control (C group), hyperhomocysteinemic pigs (M group), and folate-treated hyperhomocysteinemic pigs (M1F group). Pmax indicates systolic
blood pressure; Pmin, diastolic blood pressure; DP, pulse pressure; Pmean, mean blood pressure; Qmax, systolic blood flow; Qmin, diastolic blood flow; DQ, pulse blood flow;
Qmean, mean blood flow; Dmax, diastolic external diameter; Dmin, systolic external diameter; DD, pulse external diameter; Dmean, mean external diameter; Hm, mean wall
thickness–mean radius ration; Co, compliance; Zc, input impedance; PR, peripheral resistance; ArS, arterial wall stiffness; Ep, Young’s elastic modulus; Sm, midwall arterial stress.
p-ANOVA, p of iliac versus renal comparison according to two-way analysis of variance.
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in this model are related to thrombosis initiation at the
contact of an altered endothelium and thrombogenic sub-
endothelium structures. However, we cannot rule out the
possibility of a hemostatic abnormality because we did not
perform an exhaustive study of hemostasis. To our knowl-
edge, no abnormalities of hemostatic factors have been
found in humans with mild hyperhomocysteinemia.
Effect of a three-month folic acid treatment. Folic acid
treatment was begun one month after the onset of the
methionine-rich diet to mimic the treatment of hyperhomo-
cysteinemic humans. We verified that one month of this diet
was enough to induce a marked hyperhomocysteinemia. Folic
acid significantly lowered homocysteinemia. This result is in
accordance with previous observations in humans (10,13–15).
Despite a marked lowering in homocysteinemia, folic
acid did not prevent hemodynamic alterations, thrombotic
events, or arterial lesions. In renal arteries, hemodynamics
were similar for both the M and the M1F group. All the
pigs of the M 1 F group displayed arterial lesions similar to
the lesions of the M group. We have previously shown that
in the media of pigs fed a methionine-rich diet, there is a
30% to 50% decrease of elastin content (19). In this study,
folic acid treatment did not modify medial elastin content.
The folic acid dose given in our study was much higher
than the Recommended Daily Allowance for humans (200
mg/liter) (14). This 5-mg/day dose has been shown to
decrease plasma homocysteine levels of about 25% to 45%.
In humans, a lower dose can be efficient. For instance,
Ubbink et al. (14) obtained a 41.7% homocysteine reduction
with a daily dose of 0.65 mg folic acid for six weeks.
A possible explanation for the absence of effect on arterial
lesions in our study could be that a one-month methionine-
rich diet induced too much severe lesions to be reversed by a
three-month folic acid treatment. However, the extent of
arterial lesions one month after the beginning of the
methionine-rich diet is not known. Another explanation is that
besides homocysteine elevation, an animal-protein-rich diet
can induce arterial wall lesions by other mechanisms unknown
at the present and unaffected by folic acid treatment (21). A
third explanation could be that a concomitant administration
of vitamin B-6 and/or vitamin B-12 with folic acid is needed
to allow a prevention of arterial lesions. Vitamin B-12 is a
cofactor for homocysteine remethylation, and vitamin B-6
stimulates homocysteine transformation into cysteine. Treat-
ments with these vitamins have little effect on fasting homo-
cysteinemia in patients with mild hyperhomocysteinemia (8).
The combination of folic acid 1 vitamin B-6 1 vitamin B-12
seems not markedly more effective than folic acid monotherapy
for plasma homocysteine reduction (14).
However, the association of folic acid with either vitamin
B-6 or vitamin B-12 has theoretical advantages. Vitamin
B-6 has an additional effect while reducing homocysteine
postprandial peak (21). Vitamin B-12 may be useful in some
patients, as hyperhomocysteinemia can be due to vitamin
B-12 deficiency and as folic acid will not correct the
neuropathy due to this deficiency. We therefore propose, as
previously stressed by Ubbink (14), that homocysteine-
lowering trials in humans should use combination of
folates1vitamin B-61vitamin B-12.
Reprint requests and correspondence: Dr. Pierre Ambrosi, De-
partment of Cardiology, Hoˆpital de la Timone, 13385 Marseille, France.
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